Our Network of Board-Certified Providers
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
People living in the Journal Square area of Jersey City, New Jersey can access FDA-approved GLP-1 receptor agonist medications through a secure online telehealth consultation. Our network of NJ-licensed physicians provides personalized weight management and metabolic health treatment for patients across Hudson County.
GLP-1 medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are prescribed by board-certified doctors who understand the healthcare needs of Jersey City residents. The complete process — from assessment to medication delivery — happens online.[1][2]
Medically reviewed by
Dr. Sarah Mitchell, MD, ABOM
Board-Certified in Obesity Medicine • Last reviewed: June 4, 2026
Ozempic and Wegovy both contain semaglutide, FDA-approved for type 2 diabetes and chronic weight management, respectively. Board-certified physicians prescribe weekly semaglutide injections with personalized dose-escalation protocols informed by each patient's metabolic profile and treatment targets.
Mounjaro (tirzepatide for diabetes) and Zepbound (tirzepatide for obesity) harness the combined power of GLP-1 and GIP receptor agonism. Clinical management requires board-certified physicians skilled in dual-agonist patient selection, dose escalation to maximum 15 mg weekly, and monitoring for gastrointestinal and metabolic responses.
Landmark randomized controlled trials in the New England Journal of Medicine establish the efficacy profile of FDA-approved GLP-1 medications available to Journal Square, Jersey City residents:
Telehealth prescribing of GLP-1 receptor agonists in New Jersey is conducted by board-certified, NJ-licensed physicians through HIPAA-compliant platforms. GLP-1 medications are not DEA-scheduled controlled substances and may be prescribed via telehealth after a valid clinical evaluation.
Getting prescribed GLP-1 medication from Journal Square is fully online. No travel across Jersey City required — everything is handled through our secure telehealth platform from your home.
Complete a brief health questionnaire from your home in Journal Square. This covers your medical history, current medications, BMI, and weight management goals. Takes 2-3 minutes to complete.
A NJ-licensed physician reviews your health profile and conducts a personalized telehealth consultation. They recommend the most appropriate GLP-1 medication for your individual needs and discuss expected outcomes.
Once prescribed, your GLP-1 medication ships from a licensed US pharmacy directly to your Journal Square address. Most patients in Jersey City receive their medication within 3-5 business days in secure, temperature-controlled packaging.
Our telehealth providers serve all neighborhoods in Jersey City and surrounding areas.
Explore GLP-1 telehealth services across every neighborhood in Jersey City, NJ.
Also serving residents of cities near Jersey City.
Explore GLP-1 telehealth services in the largest cities across New Jersey.
Board-certified physicians prescribe FDA-approved GLP-1 medications through our telehealth platform, reaching patients in neighborhoods throughout the United States.
Local weight loss and GLP-1 providers serving the Journal Square, Jersey City area, based on Google Business listings.
35 Journal Square Plaza Suite #1104
(201) 575-9975
5/5 ★ (83 reviews)
35 Journal Square Plaza Unit 215
(201) 942-4555
4.9/5 ★ (94 reviews)
550 Summit Ave
(551) 486-6604
3.8/5 ★ (20 reviews)
Connect with experienced, US-licensed physicians specializing in metabolic health and GLP-1 therapy. All providers are board-certified and committed to evidence-based care.
Yes. All residents of Journal Square and the greater Jersey City, New Jersey area can access GLP-1 telehealth through our NJ-licensed providers. The entire process is online.
After physician approval, most patients in the Journal Square area of Jersey City receive their GLP-1 medication within 3-5 business days via direct home delivery from a licensed US pharmacy.
No. Everything is handled through secure telehealth — no clinic or pharmacy trips required in Jersey City. Your consultation, prescription, and delivery are all managed online from your home.
Providers can prescribe all FDA-approved GLP-1 medications to eligible Hudson County residents, including semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide (Saxenda).
Yes. All prescriptions are issued by board-certified, NJ-licensed physicians through HIPAA-compliant telehealth platforms. Medications are dispensed exclusively from verified US pharmacies.
Black Box Warning: In rodent studies, semaglutide and tirzepatide caused thyroid C-cell tumors. It is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans. These medications are contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Common side effects may include nausea, vomiting, diarrhea, constipation, abdominal pain, headache, and injection site reactions. These typically diminish as dosage is gradually escalated.
Serious side effects may include pancreatitis, gallbladder problems, kidney injury, hypoglycemia (with insulin), and allergic reactions. Consult your healthcare provider immediately if you experience severe symptoms.
Contraindications: History of medullary thyroid carcinoma, MEN 2, pancreatitis, pregnancy or breastfeeding, severe gastrointestinal disease. This is not a complete list — always discuss your full medical history with your physician.
Clinical References:
